Literature DB >> 8295190

Sleep and other symptoms in primary fibromyalgia and in healthy controls.

P Jennum1, A M Drewes, A Andreasen, K D Nielsen.   

Abstract

OBJECTIVE: To evaluate sleep architecture and self-reported complaints in patients with fibromyalgia (FS). Forty patients and 10 age standardized healthy controls were included. All participants were women.
METHODS: All patients and controls underwent a clinical examination and gave answers to a questionnaire. Polysomnography was done in 20 patients and in all controls.
RESULTS: The percent arousal time and arousal index were higher (p < 0.05 and < 0.01, respectively) among FS compared to controls, but no other differences were found in sleep architecture. Ten of the patients with FS and 2 controls showed an apnea-hypoapnea index above 5/h (NS). The arousal time and arousal index were higher in patients with apnea-hypoapnea index > or = 5 compared to controls with apnea-hypoapnea index < 5 [mean (SD)] [arousal time: 4.5 (3.2) vs 0.7 (0.7), p < 0.001, arousal index: 14.9 (10.8) vs 2.4 (3.7), p < 0.001]. In patients with FS with apnea-hypoapnea index < 5 the arousal time was higher (2.0 (1.2), p < 0.05) and arousal index marginally higher (5.6 (3.2), p = 0.07) compared to the controls. No other differences were found in sleep structure. Insomnia (difficulties falling asleep, maintaining sleep, early morning awakening), tiredness, mood, cognitive disturbances and muscular pain were all reported more commonly by patients with FS than controls. A subdivision of the patients with FS into those with apnea-hypoapnea index < 5 and apnea-hypoapnea index > or = 5 did not change these findings.
CONCLUSION: We conclude, that patients with FS show minor polysomnographic findings, with a higher occurrence of arousals. The arousals were in part explained by respiratory abnormalities. Patients with FS have several complaints, including insomnia. Some of these may relate to sleep fragmentation. Controlled studies are a requirement in investigations of sleep disorders in fibromyalgia.

Entities:  

Mesh:

Year:  1993        PMID: 8295190

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  12 in total

1.  Evaluating Evidence for the Role of Sleep in Fibromyalgia: A Test of the Sleep and Pain Diathesis Model.

Authors:  Nancy A Hamilton; Mindy Pressman; Teresa Lillis; Ruthann Atchley; Cynthia Karlson; Natalie Stevens
Journal:  Cognit Ther Res       Date:  2012-12-01

Review 2.  Polysomnographic characteristics in nonmalignant chronic pain populations: A review of controlled studies.

Authors:  Martin F Bjurstrom; Michael R Irwin
Journal:  Sleep Med Rev       Date:  2015-04-08       Impact factor: 11.609

Review 3.  Fibromyalgia and sleep in animal models: a current overview and future directions.

Authors:  Cristina Frange; Camila Hirotsu; Helena Hachul; Paula Araujo; Sergio Tufik; Monica L Andersen
Journal:  Curr Pain Headache Rep       Date:  2014

Review 4.  Insomnia and its treatment in women with breast cancer.

Authors:  Lavinia Fiorentino; Sonia Ancoli-Israel
Journal:  Sleep Med Rev       Date:  2006-09-11       Impact factor: 11.609

Review 5.  Sleep and circadian rhythm disorders in fibromyalgia.

Authors:  A Korszun
Journal:  Curr Rheumatol Rep       Date:  2000-04       Impact factor: 4.592

6.  Sleep in rheumatic diseases and other painful conditions.

Authors:  Luis F Buenaver; Michael T Smith
Journal:  Curr Treat Options Neurol       Date:  2007-09       Impact factor: 3.598

7.  Obstructive sleep apnea syndrome as an uncommon cause of fibromyalgia: a case report.

Authors:  Vesile Sepici; Aliye Tosun; Oğuz Köktürk
Journal:  Rheumatol Int       Date:  2007-06-23       Impact factor: 2.631

8.  Neurobiology underlying fibromyalgia symptoms.

Authors:  Marta Ceko; M Catherine Bushnell; Richard H Gracely
Journal:  Pain Res Treat       Date:  2011-10-27

9.  Spectrum of Clinical Features in X-Linked Myotubular Myopathy Carriers: An International Questionnaire Study.

Authors:  Stacha F I Reumers; Frederik Braun; Jennifer E Spillane; Johann Böhm; Maartje Pennings; Meyke Schouten; Anneke J van der Kooi; A Reghan Foley; Carsten G Bönnemann; Erik-Jan Kamsteeg; Corrie E Erasmus; Ulrike Schara-Schmidt; Heinz Jungbluth; Nicol C Voermans
Journal:  Neurology       Date:  2021-05-19       Impact factor: 11.800

10.  Melatonin is a biomarker of circadian dysregulation and is correlated with major depression and fibromyalgia symptom severity.

Authors:  Wolnei Caumo; Maria Paz Hidalgo; Andressa Souza; Iraci L S Torres; Luciana C Antunes
Journal:  J Pain Res       Date:  2019-01-31       Impact factor: 3.133

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.